English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Johns Hopkins researchers develop simplified nanoparticles to target disease-causing cells

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Multiple concussions linked to slightly worse health in former college athletes

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Most older adults in England believe climate change poses serious future risks

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Apixaban found to be safer than rivaroxaban in venous thrombosis trial

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Study finds parents face challenges as teens gain health decision rights at 16

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Stanford researchers identify immune system process behind food tolerance in new study

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Woven EndoBridge intrasaccular therapy shows promise for treating complex brain aneurysms

+ Community
Patient Daily | Mar 15, 2026

Experts discuss how hearing loss can affect romantic relationships and communication

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns

  • « First
  • «
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily